What factors are propelling the point of care coagulation testing device market?

Demand is driven by the need for real-time hemostasis data in surgery and emergency care, the rise in DOAC therapy, and the shift toward home-based monitoring that minimizes clinic visits. Read More

Which test type dominates current revenues?

Prothrombin Time/INR testing accounts for 57.51% of 2024 revenue because warfarin remains prevalent and requires frequent INR checks. Read More

Who are the key players in Point Of Care Coagulation Testing Devices Market?

Single-use cartridges and strips deliver 43.54% of 2024 sales, providing predictable, recurring income that cushions manufacturers from capital-equipment cycles. Read More

Which region shows the fastest growth?

Asia-Pacific records a 7.75% CAGR between 2025 and 2030, benefiting from expanding healthcare infrastructure, larger chronic-disease populations, and supportive government initiatives. Read More

What technological trend is gaining adoption in trauma care?

Viscoelastic testing delivers a full clotting profile in under 15 minutes, enabling precise transfusion management and reducing blood-product waste. Read More

What challenges could hamper future growth?

Lower laboratory reimbursement in North America and Europe and a global shortage of technicians skilled in advanced viscoelastic platforms may slow new installations in some facilities. Read More

Point Of Care Coagulation Testing Devices Companies

This report lists the top Point Of Care Coagulation Testing Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Point Of Care Coagulation Testing Devices industry.